Status:
TERMINATED
Study of HD Mesh Ablation System for Treatment of Paroxysmal Atrial Fibrillation
Lead Sponsor:
C. R. Bard
Conditions:
Paroxysmal Atrial Fibrillation
Eligibility:
All Genders
21-75 years
Phase:
PHASE3
Brief Summary
This is a randomized controlled study of the Bard High Density Mesh Ablation System for treatment of paroxysmal atrial fibrillation. This study will determine if the HD Mesh Ablation System is as safe...
Eligibility Criteria
Inclusion
- Patients with symptomatic paroxysmal atrial fibrillation who have failed at least one class I or III anti-arrhythmic drug
- Other inclusion criteria
Exclusion
- Previous surgical or catheter ablation to treat AF
- Permanent AF
- Uncontrolled or unstable medical conditions
- Other exclusion criteria
Key Trial Info
Start Date :
July 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2009
Estimated Enrollment :
44 Patients enrolled
Trial Details
Trial ID
NCT00741611
Start Date
July 1 2008
End Date
November 1 2009
Last Update
October 26 2012
Active Locations (13)
Enter a location and click search to find clinical trials sorted by distance.
1
University of California, San Diego Medical Center
San Diego, California, United States, 92103
2
Aurora Denver Cardiology Associates
Aurora, Colorado, United States, 80012
3
University of Florida
Gainesville, Florida, United States, 32610
4
Mayo Clinic
Jacksonville, Florida, United States, 32224